Pharmacokinetics in children

There is no specific data available about the kinetics in children.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Renal impaiment in children > 3 months

In cases of hepatic and/or renal function disorders, dose according to the blood levels: 0.1-7 mcg/ml (avg. 2.3 mcg/ml).

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

• ANTIINFECTIVES FOR SYSTEMIC USE
• ANTIMYCOBACTERIALS

DRUGS FOR TREATMENT OF LEPRA

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

References

1. MAE Holding BV, SmPC Dapson (RVG 52479) 05-09-13, www.cbg-meb.nl
2. RIEMSER, SmPC Dapson-Fatol 50mg Tabletten (5829.00.00), 01/2015
3. Online GL. Gelbe Liste Online, https://www.gelbe-liste.de/, Accessed June 17, 2018
4. Tillomed Pharma GmbH, SmPC Dapson Tillomed 50 mg Tabletten (99886.00.00), 09/2018

Changes

Therapeutic Drug Monitoring

Overdose